Vyome Holdings, Inc. (HIND) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−0.8x

Market Cap

$15.58M

MomentumView details →

1D Return

−0.45%

YTD Return

−37.21%

RSI (14)

46.6

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−0.8x

Market Cap

$15.58M

RSI (14)

46.6

MomentumView details →

1D Return

−0.45%

YTD Return

−37.21%

ProfitabilityView details →

Gross Margin

46.50%

Net Margin

−8716.77%

EBITDA Margin

−8886.37%

ROE (TTM)

−186.95%

ROA (TTM)

−123.23%

Asset Turnover

0.01x

GrowthView details →

Revenue YoY

−97.99%

EPS YoY

+78.26%

FCF YoY

+106.89%

Revenue CAGR 3Y

−69.47%

EPS CAGR 3Y

+98.63%

EBITDA YoY

−68.39%

EarningsView details →

EPS (Actual)

−$0.10

EPS Surprise

47.37%

Beats (12Q)

5/12

Next Q EPS Est

−$0.21

Avg Surprise (4Q)

−668.08%

Rev Surprise

0.00%

Capital & dividendView details →

Debt/Equity

0.00x

Current Ratio

4.37x

Quick Ratio

4.37x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

Financials snapshotView financials →

Revenue (TTM)

129724.00

Net Income (TTM)

−11.31M

Op. CF (TTM)

524471.00

Next earningsNov 13, 2026 →

Latest newsMore news →

Vyome Holdings appointed Jerry Leonard as Chief Financial Officer, effective September 1, 2026, succeeding Robert Dickey, who resigned as Interim Chief Financial Officer effective August 31, 2026.7d ago

Vyome Holdings reported Q2 2026 revenue of $58,546, a net loss of $720,000, and a diluted loss per share of $0.10, with cash and cash equivalents of $7.9 million as of the period end.11d ago

Similar companies

Hoth Therapeutics, Inc.HOTH Citius Pharmaceuticals, Inc.CTXR Passage Bio, Inc.PASG Pluri Inc.PLUR Lisata Therapeutics, Inc.LSTA BioCardia, Inc.BCDA Find similar companies →

Latest newsMore news →

Vyome Holdings appointed Jerry Leonard as Chief Financial Officer, effective September 1, 2026, succeeding Robert Dickey, who resigned as Interim Chief Financial Officer effective August 31, 2026.7d ago Vyome Holdings reported Q2 2026 revenue of $58,546, a net loss of $720,000, and a diluted loss per share of $0.10, with cash and cash equivalents of $7.9 million as of the period end.11d ago